You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B excipient

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Ethylcellulose Aqueous Dispersion Type B

Introduction to Ethylcellulose Aqueous Dispersion Type B

Ethylcellulose aqueous dispersion type B, commonly used in pharmaceutical applications, is a critical excipient that enhances the functionality and stability of drug formulations. This dispersion is particularly noted for its role in sustained release coatings, taste masking, and as a film-forming agent[4].

Market Size and Growth

The global market for pharmaceutical excipients, which includes ethylcellulose, is projected to grow significantly. In 2023, the market was valued at $9.2 billion and is expected to reach $12.4 billion by 2029, with a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029[3].

Ethylcellulose Specific Market Trends

Ethylcellulose, as a key component in pharmaceutical formulations, benefits from this broader market growth. Its applications in sustained release coatings and taste masking are particularly relevant, given the increasing demand for complex drug delivery systems[4].

Regional Market Analysis

The global excipients market is segmented by region, with North America, Europe, Asia-Pacific, Latin America, and the Rest of the World being the primary regions covered. Ethylcellulose is widely used across these regions due to its versatility and reliability in various pharmaceutical applications[3].

Competitive Landscape

The market for ethylcellulose is competitive, with several manufacturers offering different grades and specifications. Companies like Colorcon and other specialized chemical suppliers provide ethylcellulose in various forms, including Surelease, which is a well-established technology for sustained release coatings[4].

Regulatory Environment

The use of ethylcellulose in pharmaceuticals is subject to stringent regulatory requirements. Compliance with standards such as USP, EP, and CP is crucial for ensuring the quality and safety of drug products. The Good Manufacturing Practice (cGMP) guidelines also play a significant role in validating the manufacturing processes involving ethylcellulose[2].

Technical Specifications and Applications

Ethylcellulose is available in different grades, each with specific technical specifications such as ethoxy content, viscosity, loss on drying, and residue on ignition. It is used as a film former, binder, dispersing agent, stabilizer, water retention agent, and controlled release agent in various pharmaceutical applications[5].

Case Studies and Research

Several case studies and research papers have highlighted the effectiveness of ethylcellulose in pharmaceutical formulations. For instance, studies have shown that viscosity variation within manufacturer’s specifications for ETHOCEL Premium grades has minimal impact on drug release for extended release multiparticulates[4].

Key Takeaways

  1. Market Growth: The global excipients market is expected to grow significantly, driven by the increasing demand for complex drug delivery systems.
  2. Ethylcellulose Role: Ethylcellulose plays a crucial role in sustained release coatings and taste masking applications.
  3. Regulatory Compliance: Compliance with regulatory standards such as USP, EP, and CP is essential for ensuring the quality and safety of drug products.
  4. Competitive Landscape: The market is competitive with several manufacturers offering different grades and specifications of ethylcellulose.
  5. Technical Specifications: Ethylcellulose is available in various grades with specific technical specifications.

FAQs

  1. What is Ethylcellulose Aqueous Dispersion Type B?

    • Ethylcellulose aqueous dispersion type B is a form of ethylcellulose used in pharmaceutical applications for sustained release coatings and taste masking.
  2. How is the global excipients market expected to grow?

    • The global excipients market is expected to grow from $9.7 billion in 2024 to $12.4 billion by 2029, with a CAGR of 5.1% from 2024 to 2029[3].
  3. What are the key applications of ethylcellulose in pharmaceuticals?

    • Ethylcellulose is used as a film former, binder, dispersing agent, stabilizer, water retention agent, and controlled release agent in various pharmaceutical applications[5].
  4. What are the technical specifications of ethylcellulose?

    • Ethylcellulose is available in different grades with specifications such as ethoxy content, viscosity, loss on drying, and residue on ignition[5].
  5. How does regulatory compliance impact the use of ethylcellulose in pharmaceuticals?

    • Compliance with standards such as USP, EP, and CP is crucial for ensuring the quality and safety of drug products. The Good Manufacturing Practice (cGMP) guidelines also play a significant role in validating the manufacturing processes involving ethylcellulose[2].

Sources Cited

  1. [Global Ethyl Cellulose Aqueous Dispersion Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030][1]
  2. [EP1228125A2 - Process for making aqueous coated beadlets][2]
  3. [Excipients in Pharmaceuticals: Global Markets to 2029][3]
  4. [Surelease - Colorcon][4]
  5. [Ethyl Cellulose - Cellulose ethers| Redispersible Polymer Powder][5]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.